Polymer-Drug Nanoparticles Combine Doxorubicin Carrier and Heparin Bioactivity Functionalities for Primary and Metastatic Cancer Treatment.
Mei, Ling
Polymer-Drug Nanoparticles Combine Doxorubicin Carrier and Heparin Bioactivity Functionalities for Primary and Metastatic Cancer Treatment. [electronic resource] - Molecular pharmaceutics 02 2017 - 513-522 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1543-8392
10.1021/acs.molpharmaceut.6b00979 doi
Animals
Cell Line, Tumor
Doxorubicin--chemistry
Drug Carriers--chemistry
Drug Delivery Systems--methods
Heparin, Low-Molecular-Weight--chemistry
Hydrazones--chemistry
Male
Melanoma, Experimental--drug therapy
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Nanoparticles--chemistry
Neoplasm Metastasis--drug therapy
Neoplasms--drug therapy
P-Selectin--metabolism
Polymers--chemistry
Polymer-Drug Nanoparticles Combine Doxorubicin Carrier and Heparin Bioactivity Functionalities for Primary and Metastatic Cancer Treatment. [electronic resource] - Molecular pharmaceutics 02 2017 - 513-522 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1543-8392
10.1021/acs.molpharmaceut.6b00979 doi
Animals
Cell Line, Tumor
Doxorubicin--chemistry
Drug Carriers--chemistry
Drug Delivery Systems--methods
Heparin, Low-Molecular-Weight--chemistry
Hydrazones--chemistry
Male
Melanoma, Experimental--drug therapy
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Nanoparticles--chemistry
Neoplasm Metastasis--drug therapy
Neoplasms--drug therapy
P-Selectin--metabolism
Polymers--chemistry